Climb Bio News

Climb Bio | SCHEDULE 13G/A: Others

Feb 14 04:59

Climb Bio | 4: Statement of changes in beneficial ownership of securities-Officer Brennan Aoife

Jan 16 05:19

Climb Bio | 4: Statement of changes in beneficial ownership of securities-Officer Pimblett Emily

Jan 16 05:18

Climb Bio | 4: Statement of changes in beneficial ownership of securities-Officer Kaplan Brett

Jan 16 05:18

Climb Bio | 8-K: Current report

Jan 10 21:10

Climb Bio | 4: Statement of changes in beneficial ownership of securities-Director Thomas Stephen Basil

Jan 4 05:21

Climb Bio | 4: Statement of changes in beneficial ownership of securities-Officer Pimblett Emily

Dec 21, 2024 05:22

Climb Bio | EFFECT: Others

Nov 25, 2024 19:17

Climb Bio | CORRESP: CORRESP

Nov 21, 2024 01:14

Climb Bio | UPLOAD: Others

Nov 20, 2024 01:14

Climb Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(3.23%),Deep Track Biotechnology Master Fund, Ltd.(3.23%), etc.

Nov 14, 2024 22:31

Climb Bio | 4: Statement of changes in beneficial ownership of securities-Director WILLIAMS DOUGLAS E

Nov 13, 2024 06:52

Climb Bio | 3: Initial statement of beneficial ownership of securities-Director WILLIAMS DOUGLAS E

Nov 13, 2024 06:38

Climb Bio | S-3: Registration statement for specified transactions by certain issuers

Nov 13, 2024 05:55

Climb Bio | 8-K: Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 13, 2024 05:42

Climb Bio | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 05:03

8-K: Current report

Oct 15, 2024 19:09

Eliem Therapeutics | 8-K: Current report

Oct 3, 2024 04:20

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pimblett Emily

Sep 21, 2024 09:57

Eliem Therapeutics | 8-K: Current report

Aug 28, 2024 05:25